Abstracts

Impact of Doxycycline as STI PEP on the Gut Microbiome and Antimicrobial Resistance Gene Expression

Background: Doxycycline post-exposure prophylaxis (doxy-PEP) reduces bacterial sexually transmitted infections in men who have sex with men (MSM) and transwomen (TW) living with HIV or on HIV pre-exposure prophylaxis (PrEP). The impact on the gut bacterial microbiome and its associated antimicrobial resistance genes (ARGs) is unknown. Methods: The DoxyPEP trial compared doxy-PEP use (DP) to…

National Survey on the Use of Antibiotics as Sexually Transmitted Infection Prophylaxis in the US

Background: Doxycycline postexposure prophylaxis (doxyPEP) is effective for preventing bacterial sexually transmitted infections (STIs) among people assigned male sex at birth. However, little is known about real-world use of antibiotics as STI prophylaxis, including prevalence and patterns of use, reasons for use, and potential user concerns. Methods: We conducted a national online survey in September…

Doxy-PEP Effectiveness in Men Who Have Sex With Men (MSM) and Transgender Women (TGW) on HIV PrEP

Background: Doxycycline post-exposure prophylaxis (doxy-PEP) reduced the risk of chlamydia (CT), gonorrhea (GC) and early syphilis (ES) in MSM and TGW in randomized trials. Little is known about doxy-PEP effectiveness on STI positivity outside of clinical trials. Methods: Starting 11/3/22, doxy-PEP was offered to patients receiving PrEP at San Francisco City Clinic who were eligible…

No Significant Interactions From Hormone Therapy on F/TAF-Based PrEP in Trans Women: iFACT3 Study

Background: We previously observed comparable plasma and urine levels of tenofovir (TFV) and emtricitabine (FTC), as well as intracellular tenofovir-diphosphate (TFV-DP) and emtricitabine-triphosphate (FTC-TP) concentrations in peripheral blood mononuclear cells (PBMCs), when F/TAF-based oral daily PrEP was administered with and without feminizing hormone therapy (FHT) in trans women in Thailand. We assessed the potential impact…

NLPrEP Trial 24-Week Data: Nurse-Led PrEP Superior to Physician-Led PrEP Among Cis Women in Zambia

Background: There is significant interest in HIV pre-exposure prophylaxis (PrEP) among women in sub-Saharan African countries like Zambia. Oral PrEP uptake with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) may be limited by access to physicians to prescribe PrEP, and concern for kidney and bone mineral density abnormalities. PrEP with tenofovir alafenamide (TAF) and FTC…

PrEP Indicators by Race/Ethnicity Among Heterosexual Women Receiving CDC-Funded HIV Testing Services

Background: Pre-exposure prophylaxis (PrEP) is effective at reducing the risk of HIV acquisition. However, PrEP utilization among women remains low, especially among Black/African American (hereafter referred to as Black) and Hispanic/Latina women. We examined indicators for PrEP use and PrEP-related services by race/ethnicity among heterosexual women testing negative for HIV infection via CDC-funded HIV testing.…